Private‑equity firm Frazier Healthcare Partners appointed veteran executive Randy Hyun as an executive‑in‑residence. Hyun will spend the next year scouting and evaluating deals within the pharmacy services sector, leveraging his two‑decade track record in health‑care operations. The move adds a seasoned operator to Frazier’s deal‑sourcing team as the market eyes consolidation after recent regulatory shifts, as competition intensifies among buyout funds seeking niche expertise.

Frazier, which manages roughly $7 billion across multiple health‑care platforms, has been expanding its footprint in specialty services. Hyun’s background includes senior roles at CVS Health and Optum, where he oversaw pharmacy network integration and cost‑containment initiatives. His presence is expected to accelerate Frazier’s pursuit of high‑margin, technology‑enabled pharmacy assets that can generate steady cash flows, and to tap emerging digital prescription platforms.

Investors will watch the partnership for early indicators of deal flow, as pharmacy services have attracted premium valuations in recent quarters. By embedding an industry insider, Frazier aims to reduce due‑diligence risk and negotiate better terms on acquisitions. The appointment underscores a broader trend of private‑equity firms hiring operating executives to sharpen sector expertise and improve portfolio returns, and could boost fund‑level IRR.